291 related articles for article (PubMed ID: 35979260)
1. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches.
Badami E; Busà R; Douradinha B; Russelli G; Miceli V; Gallo A; Zito G; Conaldi PG; Iannolo G
World J Gastroenterol; 2022 Jun; 28(22):2417-2428. PubMed ID: 35979260
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
5. Characterization of circulating miRNAs in the treatment of primary liver tumors.
Umezu T; Tanaka S; Kubo S; Enomoto M; Tamori A; Ochiya T; Taguchi YH; Kuroda M; Murakami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1964. PubMed ID: 38146079
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis.
Huang Y; Chen Y; Tu S; Zhang J; Qiu Y; Yu W
BMC Infect Dis; 2022 Apr; 22(1):323. PubMed ID: 35365115
[TBL] [Abstract][Full Text] [Related]
9. Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma.
Shabangu CS; Su WH; Li CY; Yu ML; Dai CY; Huang JF; Chuang WL; Wang SC
J Transl Med; 2024 Mar; 22(1):268. PubMed ID: 38475805
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Meringer H; Shibolet O; Deutsch L
World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
Cevik O; Li D; Baljinnyam E; Manvar D; Pimenta EM; Waris G; Barnes BJ; Kaushik-Basu N
J Biol Chem; 2017 Dec; 292(52):21676-21689. PubMed ID: 29079574
[TBL] [Abstract][Full Text] [Related]
15. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
Thibault PA; Wilson JA
Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA in HCV infection and liver cancer.
Kumar A
Biochim Biophys Acta; 2011; 1809(11-12):694-9. PubMed ID: 21821155
[TBL] [Abstract][Full Text] [Related]
17. Direct Relationship between Interleukin-10 Gene Polymorphism and Hepatocellular Carcinoma Complicated by Direct Acting Antiviral Treatment of Hepatitis C Virus.
Ghanm SE; Shebl NA; El Sayed IET; Abdel-Bary HM; Saad BF; Othman Saad W
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3203-3210. PubMed ID: 34710996
[TBL] [Abstract][Full Text] [Related]
18. Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment.
Park SJ; Hahn YS
Clin Mol Hepatol; 2023 Jan; 29(1):65-76. PubMed ID: 35957546
[TBL] [Abstract][Full Text] [Related]
19. Complex interactions between microRNAs and hepatitis B/C viruses.
Fan HX; Tang H
World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.
Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D
World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]